Universal Cancer Immunotherapy via Pan-Tumoral Biomarker Targeting (2)

This article provides an overview of the novel mechanisms and approaches to treat cancers of various tissue origins with high precision through finding traits unique to and appliable for all types of cancer.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-20
DOI
https://doi.org/10.5281/zenodo.15253126
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Universal Cancer Immunotherapy via Pan-Tumoral Biomarker Targeting (2)

Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
article

Universal Cancer Immunotherapy via Pan-Tumoral Biomarker Targeting (2)

article en

Abstract

This article provides an overview of the novel mechanisms and approaches to treat cancers of various tissue origins with high precision through finding traits unique to and appliable for all types of cancer.

Zenodo (CERN European Organization for Nuclear Research)
Andijan State Medical Institute (UZ)
Good health and well-being
Openalex Percentile: Top 43%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Universal Cancer Immunotherapy via Pan-Tumoral Biomarker Targeting (2) · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS